REVOFIL® AQUASHINE Soft Filler is designed with a combination of monophasic and biphasic characteristics, which ensures its smooth application and effectiveness. The hyaluronic acid content in the product is 23 mg/mL, and it is complemented by two key peptides, Oligopeptide-72 (CG-Boostrin) and Oligopeptide-50 (CG-Glamerin). These peptides work synergistically to inhibit hyaluronidase and increase the synthesis of collagen and hyaluronic acid in the skin, promoting a youthful appearance with long-lasting effects.

Key Features:

• Cross-linked hyaluronic acid: 23 mg/mL, non-animal origin.
• Peptide Complex: Includes Oligopeptide-72 (CG-Boostrin) to inhibit hyaluronidase, and Oligopeptide-50 (CG-Glamerin) to enhance collagen and hyaluronic acid production.
• Viscoelastic Properties: High elasticity and stability for long-lasting effects.
• Homogeneous Gel: Monophasic and uniform in structure for smooth injection.
• Pre-filled Syringes: Each syringe contains 1 mL of filler.

REVOFIL® AQUASHINE Soft Filler is indicated for various aesthetic treatments that address the visible signs of aging, including wrinkle reduction, skin rejuvenation, and facial volume restoration. It is particularly effective in the treatment of fine lines, deep wrinkles, and volume loss in areas such as the cheeks, lips, and jawline. Additionally, it is useful for tear troughs, nasolabial folds, and temporal region enhancement.

Indications:

• Superficial Wrinkles: Correction of fine lines and surface-level wrinkles.
• Deep Wrinkles: Filling deep lines and enhancing facial contours.
• Volume Restoration: Rebuilding volume in areas like cheeks, chin, and jawline.
• Facial Rejuvenation: Suitable for areas such as the forehead, nasolabial folds, and marionette lines.
• Skin Hydration: The peptide complex provides moisture retention and revitalization.

Contraindications:

• Hypersensitivity: Not recommended for individuals allergic to hyaluronic acid or any components of the filler.
• Skin Infections: Should not be used on areas with active infections, inflammation, or irritation.
• Pregnancy and Breastfeeding: Not recommended for use during pregnancy or lactation.
• Minors: Not suitable for children under 18 years of age.

Side Effects:

• Common: Mild redness, swelling, or bruising at the injection site.
• Uncommon: Allergic reactions, infections, or prolonged swelling.
• Rare: Nodules or granulomas, which should be treated immediately if they persist.

REVOFIL® AQUASHINE Soft Filler features a unique cross-linked hyaluronic acid base that is complemented by a potent peptide complex. The cross-linking process enhances the filler’s stability, allowing it to maintain its structure within the skin for extended periods. The product is formulated to be biodegradable and naturally absorbed over time. It also contains two significant peptides—CG-Boostrin, which inhibits hyaluronidase activity, and CG-Glamerin, which promotes collagen synthesis and helps to increase skin firmness.

Ingredients:

• Hyaluronic Acid: 23 mg/mL, provides deep hydration and supports skin elasticity.
• CG-Boostrin (Oligopeptide-72): Inhibits hyaluronidase to preserve hyaluronic acid in the skin.
• CG-Glamerin (Oligopeptide-50): Enhances collagen and hyaluronic acid synthesis to improve skin texture.
• Phosphate Buffered Saline (PBS): A stabilizing solution used to maintain the pH and isotonicity of the filler.

Packaging:

• Syringe Size: 1 mL per pre-filled syringe.
• Needle Size: 30G for precision and minimal discomfort during injection.
• Packaged in sterile blister packs to ensure hygiene and safety during the injection process.

The injection procedure for REVOFIL® AQUASHINE Soft Filler requires a trained practitioner to carefully assess the treatment area. The filler is injected into the dermal layer using a fine 30G needle, typically at a depth between the superficial dermis and the mid-dermis, depending on the area being treated. The procedure is minimally invasive and usually takes between 30-60 minutes, depending on the number of areas treated. The filler is injected with steady pressure, ensuring even distribution across the treatment area.

Method of Use:

1. Preparation: Clean and disinfect the treatment area to prevent infection.
2. Injection: Using a fine needle (30G), inject REVOFIL® at the appropriate depth for each targeted area, applying consistent pressure to the syringe.
3. Post-Treatment: After the injection, patients may experience mild swelling or redness, which typically resolves within a few hours to days. It is advised to avoid direct sunlight, heavy exercise, or alcohol consumption for 24-48 hours post-treatment.
4. Follow-up: Results may last 6-12 months, depending on the area treated, the severity of wrinkles, and the patient’s skin type. Touch-ups can be done to maintain optimal results.